½÷¥ß¬ã¨s³¡§Ö°T
¬d¬Ý©õ¤é¬ã¨s³¡§Ö°T Âà±Hµ¹ªB¤Í §K¶O­q¾\ ·N¨£´£¨Ñ English Version
Phillip Home   6¤ë13¤é (¬P´Á¥|)

 

¥CÜg¬ì§Þ(1478)
¸Ñºc¡G
¥CÜg¬ì§Þ(1478)°í«ù¥H¤¤°ªºÝÄá¹³ÀY¼Ò²Õ¬°µo®i­«ÂIªº²£«~µ²ºc¤É¯Åµ¦²¤¡A­«ÂI±À¶i3200¸U¹³¯À¤Î¥H¤W¡B¥ú¾Ç¨¾§Ý¡B¼ç±æ¦¡ÅܵJ¡B¤jªä¤ù¡B¨®¸ü¼Ò²Õ¡BIoT²×ºÝÀ³¥Î¼Ò²Õµ¥¤¤°ªºÝÄá¹³ÀY¼Ò²Õ²£«~ªº¥«³õ©Ý®i¡C¤µ¦~4¤ë¡A¨ä¤¤°ªºÝÄá¹³ÀY¼Ò²Õªº¥X³f¦û¤ñ¹F¨ì¬ù46%¡A¸û2023¦~ªº¬ù41.6%´£¤É4.4­Ó¦Ê¤ÀÂI¡A¥þ­±¹ê²{¤F¶°¹Î©ó2023¦~3¤ë¤Î8¤ë¥ý«á´£¥Xªº²£«~µ²ºcÀu¤Æ·~°È¥Ø¼Ð¡A¨Ã±À°Ê¶°¹ÎÄá¹³ÀY¼Ò²Õ³æ»ù¤î¶^¦^¤É¡C¥t¤@¤è­±¡A¶°¹Î¾Ô²¤©Ê¥¬§½ªºIoT©M¨®¸üÄá¹³ÀY¼Ò²Õ²£«~¾P°â¼Æ¶q¥çí°·¼Wªø¡A©óÀç·~¦¬¤Jªº¦û¤ñ©úÅã¼W¥[¡A³v¨B®i²{¾Ô²¤©Ê¥¬§½ªº¦¨ªG¡A¤×¨ä¬O¦b¨®¸ü¼Ò²Õ·~°È¤è­±¡A¶°¹Î»P¤¤°ê·s¯à·½¨T¨®¥X³f¼Æ¶q«e¤Q¤j¨T¨®«~µP¤¤ªº¤C­Ó¨T¨®«~µP«Ø¥ß¤F·~°È¦X§@Ãö«Y¡A¤]»P¦h®a¼Ú¬ü¤Î¤¤°ê»â¥ýªº´¼¯à¾r¾p¨t²Î¤è®×¤½¥q«Ø¥ß¤F·~°È¦X§@Ãö«Y¡A¦¨¬°¦h´Ú¼ö½æ·s¯à·½¨T¨®ªº¨®¸ü¼Ò²Õ®Ö¤ß¨ÑÀ³°Ó¡A¬°¨ä´£¨Ñ¥]¬A¥ý¶i¾r¾p»²§U¨t²Î(ADAS)¡BÀôµø¡B´¼¯à®y¿µµ¥¦UºØÃþ§Oªº´¼¯à¾r¾p¨®¸ü¼Ò²Õ¡C©óIoT²×ºÝ¤è­±¡A¤µ¦~AR/VRÀYÅã¥X³f¶q¹w¦ô¦P¤ñ±N¼Wªø46.4%¡A¨ä¤¤¤¤°êªºAR¥X³f¶q±N«ùÄò°ª³t¼Wªø¡A¼W³t¹w­p°ª¹F101%¡C¦¹¥~¡A¤¤°ê´¼¯à®a©~¥«³õ»Ý¨D±N³v¨B¦^·x¡A¤µ¦~«×ªº³]³Æ¥X³f¶q¹w­p±N¦P¤ñ¼Wªø6.5%¡CIoT´¼¯à²×ºÝªº»Ý¨D¤W¤É¦³±æµ¹Äá¹³ÀY¼Ò²Õ±a¨Ó¨}¦nªº¥«³õ¾÷·|¡C¦¹¥~¡A¤H¤u´¼¯à²£·~¦b¹L¥h±o¨ì¤Fªø¨¬µo®i¡A·Pª¾´¼¯à¬O¤H¤u´¼¯à«D±`­«­nªº¤@Àô¡A¦Ó¾÷¾¹µøı¬O·Pª¾´¼¯à³Ì­«­nªº¤@Àô¡AÄá¹³ÀY¼Ò²Õ§@¬°¾÷¾¹µøıªº³Ì­«­n©M³Ì¦¨¼ôªº¹ê²{¤â¬q¡A¤]±N¦b¤H¤u´¼¯à®É¥Nªï¨Ó­«¤jµo®i¾÷¹J¡C(µ§ªÌ¨S¦³«ù¦³¤W­zªÑ²¼)
µ¦²¤¡G
¶R¤J»ù$3.60¡A¥Ø¼Ð»ù$4.00¡A¤î»k»ù$3.45
 

²`¦`°ê»Ú(152)
¸Ñºc¡G
ºI¦Ü2023¦~12¤ë©³¤î¤§¦~«×¡A²`¦`°ê»Ú¡]00152¡^¹ê²{Á`¦¬¤J¬ù205.24»õ¤¸¡]´ä¹ô¡D¤U¦P¡^¡A¸û¥h¦~¦P´Á¤W¤É32%¡A¥D­n¥Ñ©óª«¬y¶éÂ૬¤É¯Å·~°È¤¤«e®ü¦í¦v¶µ¥ØÀ[«°ÑáÆW¨½©ó¥»¦~«×µ¤¤u¥æ¥I¡A½T»{¦¬¤J¬ù55»õ¤¸¡CªÑªFÀ³¦û¬Õ§Q¸û¥h¦~¦P´Á¤W¤É52%¦Ü¬ù19.02»õ¤¸¡C¤½¥q¦b¥þ°êªñ40­Óª«¬y¸`ÂI«°¥«¹ê²{§G§½¡AºÞ²z¤Î¸gÀç37­Óª«¬y´ä¶µ¥Ø¡AÁ`¹BÀç­±¿n¹O476¸U¥­¤è¦Ì¡C©ó2023¦~©³¡A¤½¥q¤wÀò¨ú¸gÀçÅvªº¤g¦a­±¿n¬ù908¸U¥­¤è¦Ì¡A¨ä¤¤¦b¤jÆW°Ï¤wÀò¨ú¸gÀçÅvªº¤g¦a­±¿n¹O260¸U¥­¤è¦Ì¡A¸û¥h¦~¦P´Á¼W¥[¬ù60¸U¥­¤è¦Ì¡C®i±æ2024¦~¡A¨Ì°U«°¥«°t®M°ò¦³]¬I¶}µo¹BÀç¤è­±ªº¶Ç²ÎÀu¶Õ¡A³ò¶ª«¬y¡B´ä¤f¡B¦¬¶O¤½¸ô¡B¤jÀô«O¥|¤j®Ö¤ß·~°È¡A¹w®Æ¤½¥q¥i«ùÄò´£°ª¸gÀç®Ä¯q¡A§ïµ½¬Õ§Q¤ô¥­¡C
µ¦²¤¡G
¶R¤J»ù$6.82¡A¥Ø¼Ð»ù$7.56¡A¤î»k»ù$6.36

ùÚ¦w°ê»Ú (1044.HK) - FY2023·~°È¤´¿ý±oí°·¼Wªø¡B°ªºÝ°ª¤ò§Q²£«~«ùÄò¼Wªø
ùÚ¦w°ê»Ú³Ð¥ß©ó1985¦~¡A¬O¥Ø«e°ê¤º³Ì¤jªº¥Í¬¡¥Î¯È©M°ü¥®½Ã¥Í¥Î«~»s³y°Ó¡AºX¤U¾Ö¦³¦wº¸¼Ö¡B¤ß¬Û¦L¡B¤C«×ªÅ¶¡¡B¦w¨à¼Ö¥|ªT¤¤°ê¹£¦W°Ó¼Ð¡A½Ã¥Í¤y¡B¯È§¿¿Ç¡B¥Í¬¡¥Î¯È¤T¤j¥D¾É²£«~¦b°ê¤º¥«¦û²v¦W¦C«e­T¡C......§ó¦h

2024¦~²Ä¤@©u¡G´¼¯à¤â¾÷¥«³õªº°ª¶¥¤ÆÁͶÕ

ÀHµÛ2024¦~²Ä¤@©uªºµ²§ô¡A¥þ²y´¼¯à¤â¾÷¥«³õ¦A¦¸ÃÒ©ú¤F¨ä«ùÄòªº¦¨ªø°Ê¯à©M§Þ³Nºt¶iªº§Ö³t¨B¥ï¡C®Ú¾ÚCounterpoint Researchªº¼Æ¾Ú¡A¥þ²y´¼¯à¤â¾÷¥X³f¶q¦~¼W6%¡A¦ÓÁ`¦¬¤J§ó¬O¦~¼W7%¡A¹F¨ì­º©u¾ú¥v·s°ª¡C³o¶µ¦¨ÁZªº¨ú±o¡A¥D­n±o¯q©ó·s¿³¥«³õªº±j«l»Ý¨D¥H¤Î°ªºÝ³]³......§ó¦h


  • ¬ü°êÁpÀx§½Ä³®§«á«Å¥¬ºû«ù§Q²v¤£ÅÜ¡A¹w­p¤µ¦~¤º¥u·|´î®§¤@¦¸¡A¸û3¤ëij®§®É¹w´Áªº3¦¸´î®§¦æ°Ê¡A´î¤Ö2¦¸¡C¥D®uÀj«Âº¸·|«á¦b°OªÌ·|ºÙ¡A³qµÈ¤w¸g¹ê½è©ñ½w¡A¦ý¤´µM¤Ó°ª¡A¤µ¦~¥H¨Óªº³qµÈ¼Æ¾Ú¡AÁÙ¤£¨¬¥Hµ¹ÁpÀx§½´î®§ªº«H¤ß¡CÀj«Âº¸ªí¥Ü¡AÁp¨¹¤½¶}¥«³õ©e­û·|(FOMC)¤¤¨S¦³©e­û¹ï§Q²v¹w´ú§@¥X±j¯P©Ó¿Õ¡A¥ç¨S¦³¸Õ¹Ï³q¹L¹w´úµo¥X±j¯P«H¸¹¡C¥L¤S»¡¡A没¦³©e­û±N¦A¦¸¥[®§§@¬°°ò¥»°²³]¡A©Ò¦³©e­û³£¦P·N¬Fµ¦±N®Ú¾Ú¼Æ¾Ú§@¥X¨M©w¡C
  • ¼Ú·ù°õ©e·|«Å¥¬¡A±N¹ï¤¤°ê¶i¤fªº¹q°Ê¨®¼x¦¬°ª¹F38.1%ÃB¥~Ãöµ|¡AÃöµ|¥i¯à¦b7¤ë«e¹ê¬I¡C¤ñ¨È­}(01211)±N³Q¼x¦¬Ãöµ|17.4%¡A¦N§Q¨T¨®(00175)±N³Q¼x¦¬Ãöµ|20%¡A¤W¨T±N³Q¼x¦¬Ãöµ|38.1%¡F¨ä¥L°t¦X½Õ¬dªº¤½¥q±N­±Á{21%ªºÃöµ|¡A¤£°t¦X½Õ¬dªº¤½¥q±N­±Á{38.1%ªºÃöµ|¡C
  • °ê»Ú°]¸g
    • ¬ü°ê5¤ë®ø¶Oª«»ù«ü¼Æ(CPI)«ö¤ë«ù¥­¡A¹w´Á¬°¤É0.1%¡A«e­È¬°º¦0.3%¡F«ö¦~¤É3.3%¡A¹w´Á¤Î«e­È§¡¬°º¦3.4%¡C´Á¤º¡A®Ö¤ßCPI«ö¤ë¤É0.2%¡A¹w´Á¬°º¦0.3%¡F«ö¦~¤É3.4%¡A¹w´Á¬°º¦3.5%¡A«e­È¬°¤É3.6%¡C¬ü°ê5¤ë¥Á¶¡³¡ªù¨C©P¥­§¡¹ê½è©Ò±o¤W¤É0.4%¡C
    • ¦³³ø¹D«ü¡A­ì¥»¯A¤ÎÃÄ©ú¥Íª«(02269)©MÃÄ©ú±d¼w(02359)ªº¬ü°ê¡m¥Íª«¦w¥þªk®×¡n¡A¦b¯Ç¤J¡m°ê¨¾±ÂÅvªk®×¡n(NDAA)¥ßªk¹Lµ{¤¤¨üªý¡C¤º¦a´CÅé¤Þ­zÃÄ©ú±d¼wºÞ²z¼h¦^À³ºÙ¡A¤½¥q¤F¸Ñ¨ì¡AÃö©ó±N¡m¥Íª«¦w¥þªk®×¡n¥[¤J2025°ê¨¾±ÂÅvªk®×ªº­×¥¿®×¡A¥¼¯àÀò±o²³Ä³°|³W«h©e­û·|ªº§å­ã¡A¦]¦¹¡m¥Íª«¦w¥þªk®×¡n¥Ø«e¤£·|¶i¤J²³Ä³°|ªº2025°ê¨¾±ÂÅvªk®×ªº¥ßªkijµ{¡A¨ä«áÄò¥ßªk¸ô®|¤´¦³«Ý©ú½T¡C
    • ¤º¦a´CÅé³ø¹D¡A½«¨Ó(09866)¹ï¥þ²y·~°È¶i¦æ³Ì·s¤@½üªº²Õ´½Õ¾ã¤Î¤H¨Æ¥ô©R¡C¾Ú¤º³¡¤½§i¡A½«¨Ó·s³]¤@¯Å³¡ªù¡u¥þ²y·~°Èµo®i¡v(GB)¡A­t³d¦h«~µP¤Î¦h°Ï°ì¥þ²y·~°Èªº©Ý®i¡A¥Ñ¡u¥X®ü¦Ñ±N¡v³¯±á¾á¥ô­t³d¤H¡A¦V½«¨ÓÁp¦X³Ð©l¤H¡BÁ`µô¯³¤O¬xúÀ³ø¡C
  • ¥D­nÉ]³õ
    • ¤º¦aªÑ¥«­Ó§Oµo®i¡A¤WÃÒ«ü¼Æ¦­¬q¦b¯¶´T¤ô¥­¤W¸¨¡A³Ì¦h¶^6ÂI©Î0.22%¡A§C¨£3021ÂI«á¦³©Ó±µ¨«°ª¡A³Ì¦h¤É13ÂI©Î0.46%¡A°ª¨£3042ÂI¡A¥þ¤é¦¬¥«³ø3037ÂI¡A¤É9ÂI©Î0.31%¡A¦¨¥æ3120.59»õ¤¸¤H¥Á¹ô¡C²`¦¨«ü³Ì¦h¶^18ÂI©Î0.2%¡A§C¨£9243ÂI«á¤ÏÂоaí¡A³Ì¦h¤É37ÂI©Î0.4%¡A°ª¨£9299ÂI¡A¥þ¤é¦¬¥«³ø9269ÂI¡A¤É7ÂI©Î0.08%¡A¦¨¥æ3798.54»õ¤¸¡C¥«³õ¥æ§ë²¨¸¨¡A¨â¥«¦¨¥æ¦X­p¶i¤@¨BÁY´î¦Ü6919»õ¤¸¡C
    • ¨È¤Ó°ÏªÑ¥«­Ó§Oµo®i¡A¥«³õÆ[±æÁpÀx§½Ä³®§Án©ú¤Î¬ü°ê³qµÈ¼Æ¾Ú¡A¥H¿Å¶q·í§½¦ó®É±Ò°Ê´î®§¡C¤é¥»ªÑ¥«²×¤î³s¤É¨â¤é¡A¤é¸g¥­§¡«ü¼Æ¦¬³ø38876ÂI¡A¶^258ÂI©Î0.66%¡C
    • ij®§µ²ªG¥XÄl«e¡A³Ì·s¼Æ¾ÚÅã¥Ü¬ü°ê³qµÈ§e­°·Å¸ñ¶H¡A¨ë¿E¬üªÑ¦­¬q³y¦n¡A¹D«ü°ª¶}203ÂI«á¡A¤É´T´¿ÂX¤j¦Ü372ÂI¡A°ª¨£39120ÂI¡F¼Ð«üÄò´M³»¡A¤@«×´­¤É1.34%¦Ü5447ÂI¡F¯Ç«ü¥ç¯}³»¡A³Ì¦hº¦2.2%¦Ü17725ÂI¡Cij®§µ²ªG¤½¥¬«á¡A¹D«ü³Ì¦h­Ë¶^125ÂI¡A§C¨£38621ÂI¡F¼Ð«ü»P¯Ç«üºû«ù°ª¦ì¤W¸¨®æ§½¡C¬ü¥«¦¬¥«¡A¹D«ü¦^¦R35ÂI©Î0.09%¡A³ø38712ÂI¡F¼Ð«ü¤É´TÁY¯¶¦Ü0.85%¡A³ø5421ÂI¡F¯Ç«ü¤´º¦1.53%¡A³ø17608ÂI¡A¯Ç«ü»P¼Ð«ü§¡³Ð¦¬¥«¾ú¥v·s°ª¡C
  • Àô²yºîµû
    • ¬ü°ê³qµÈ¼Æ¾Ú¸û¹w´Á·Å©M¡AÁpÀx§½9¤ë´î®§¥i¯à©Ê¤É·Å¡A²o°Ê¬ü¤¸¶×»ù°¾³n¡A¦ý§C¦ì¦³§Þ³N¶R½L¤ä«ù¡C¬ü¶×«ü¼Æ´¿§C¨£104.257¡A¶^´T¹F¨ì0.92%¡C

    ¬ü°ê³qµÈ¼Æ¾Ú·Å©M¡A¥H¤ÎÁpÀx§½©x­û¹w´Á¤µ¦~¥u´î®§¤@¦¸µ¥°T®§¬Û¤¬©è®ø¼vÅT¡A¬ü¤¸¶×»ù°¾³n¡A²o°Ê°ê»Úª÷»ù¥ý¤É«á¦^¡C¯Ã¬ù´Áª÷¦¬¥«¤É28.2¬ü¤¸¡A¨C¯s´µ³ø2354.8¬ü¤¸¡C...... §ó¦h

    ¦ÊÀÙ¯«¦{ (6160.HK)
    ¬ã¨s³ø§i: ¦ÊÀÙ¯«¦{(6160.HK) : ¥Ø¼Ð»ù122.00´ä¤¸¡C¦ÊÀÙ¯«¦{¦¨¥ß©ó 2010 ¦~¡A¬O¥»¤g³Ð·sÃÄ¥X®üÀsÀY¡A»EµJ¤_¸~½Fªº³Ð·s«¬¤À¤l¹v¦V¤Î¸~½F§K¬ÌªvÀøÃĪ«ªº¬ãµo¤Î°Ó·~¤Æ¡A¬O­º®a¹ê²{¬üªÑ+HªÑ+AªÑ¤T¦a¤W¥«ªº³Ð·sÃÄ¥ø·~¡C¤½¥q¹ê¤O¨ô¶V¡A¨ã³Æ¦­´ÁÃĪ«µo²{¡BÁ{§É¬ã¨s¡B³W¼Ò¤Æªº°ª½è¶qÃĪ«¥Í²£¤Î°Ó·~¤Æµ¥¥þ¤è¦ì¤@Åé¤Æ¯à¤O¡C¤½¥qªº¥|­Ó¥D­nªÑªF¥]¬A¦w¶i¡BBaker Brothers Life Sciences, L.P.¤Î¨ä¤@­P¦æ°Ê¤H¡BHHLR Fund, L.P.¤Î¨ä¤@­P¦æ°Ê¤H¡BCapital Research and Management Company ¤Î¨ä¤@­P¦æ°Ê¤H¤À§O«ùªÑ 18.25%¡B11.30%¡B10.89%¡B7.92%¡A¨ä¤¤³Ì¤jªÑªF¦w¶i¡A¬O¥þ²y±Æ¦W«e20 ¦ìªº¥Íª«ÂåÃĤ½¥q¡C¦ÊÀÙ¯«¦{ªººÞ½u«p«×¤Î¦h¼Ë¤Æµ{«×¦ì©~¥þ²yÄvª§«e¦C¡C¥Ø«e³B©óÁ{§É¤Î°Ó·~¤Æ¶¥¬qªºÃĪ«¬ù 50 ­Ó¡A¤w¤W¥«ÃĪ« 16 ­Ó¡]¥]¬A¦Û¬ã²£«~ 3 ­Ó¡^¡A³B©óÁ{§É¢»´Á¶¥¬qªºÃĪ« 3­Ó¡A³B©óÁ{§É¢º´Á¶¥¬qªºÃĪ« 13 ­Ó¡A³B©óÁ{§É¢¹´Á¶¥¬qªºÃĪ« 18 ­Ó¡C¥t¥~¾Ö¦³ 60 §E¶µÁ{§É«e·sÃĶµ¥Ø¡A³o¨ÇÃĪ«Ãþ«¬¯A¤Î¤p¤À¤lÃÄ¡B³æ§Ü¡BÂù§Ü¡BADC µ¥¦hºØÃþ«¬¡A¦h´ÚÃĪ«¨ã³Æ®t²§¤Æ¤D¦Ü¡§first-in-class¡¨¼ç¤O¡CÂ×´I¡B¦h¤¸¤Æªº¬ãµoºÞ½u¼sªxÂл\¤F¥þ²y 80%ªºÀù¯gÃþ«¬¡]«öµo¯f²v­pºâ¡^¡C¦b¦Û¬ã¤è­±¡A¦ÊÀÙ¾Ö¦³¨ô¶Vªº¤º³¡¶}µo¯à¤O¡A¾Ö¦³¶W 900 ¤HªºÁ{§É«e¬ã¨s¹Î¶¤¡A¦Û¥D¬ãµo²£«~¤¤¥Ø«e¦@¦³ 11 ´Ú²£«~¶i¤J¨ì°Ó·~¤Æ¶¥¬q¤ÎÁ{§É¹êÅ綥¬q¡A¨ä¤¤¦³ 3 ´Ú¤w¸gÀò§å¤W¥«¡A¤À§O¬°¿A¥¬´À¥§½¦Ån¡B´À¹p§Q¯]³æ§Üª`®g²G¡B©¬¦Ì©¬§Q½¦Ån¡A¥t¥~ 8 ´Ú²£«~³B©óÁ{§É¹êÅ綥¬q¡A¥B¬°®t²§¤Æ³]­pªº³Ð·sÃĪ«¡C¦b¦X§@¤è­±¡A¦ÊÀÙ¯«¦{ License in/out±j¤j¡ABD ¯à¤O³B©ó¥þ²y«e¦C¡A2017 ¦~»P·s°ò¤½¥q¡]²{ÁõÄݤ_¦Ê®É¬ü¬I¶QÄ_¡^¹F¦¨¦X§@¡A2019 ¦~©³»P¦w¶i­q¥ß¦X§@¨óij¡A2021 ¦~ 1 ¤ë»P 12 ¤ë¤À§O»P¿ÕµØ¹F¦¨¦X§@¡A¥ý«á¤Þ¶i13 ´Ú°Ó·~¤Æ²£«~ªº¤¤°êÅv¯q¡A¥]¬A¦w¶iªº¦w¥[ºû¡B­¿§Q§´¡B³Í¬¥´µ¡ABMS ªº·ç½Æ¬ü¡Bºû¹F²ï¡AEUSAPharmaªºÂÄ·ÅÏÈ¡B³Í¿A¦Ê¡A¦Ê¶ø®õªº´¶¨©§Æ¡A¥H¤Î¿ÕµØªº®õµá¼Ö¡BÁÚ¦NÚ¬¡Bºû¥þ¯S¡B­¸¥§§´¡BÃÙ¥i¹Fµ¥³Ð·s²£«~¡C¤½¥q¦bÁ{§É¶}µo¡BÁ{§Éµ¦²¤¡BÁ{§É°õ¦æµ¥¤è­±´I¦³¸gÅç¡A¥Ø«e¦b¥þ²y¾Ö¦³3,500+¥B¤´µM¤£Â_¼Wªøªº°Ó·~¤Æ¹Î¶¤¡A¨ä¤¤¤¤°ê¹Î¶¤3,000+¦W¡AÂл\¶W¹L 1,000 ®aÂå°|¡C¤½¥qªº¬ãµo§G§½¤wÂл\ ADC¡BÂù§Ü/¦h§Ü¡BCDAC¡]PROTAC¡^¡BCAR-NK¡BmRNA µ¥¦b¤ºªº¦hºØ¤j/¤p¤À¤lÃĪ«¥H¤Î·sªºÃĪ«§Î¦¡¡A¹w­p±N¦³±æ±a¨Ó«ùÄòªº³Ð·s²£«~¿é¥X¡C°]°È¼Æ¾ÚÅã¥Ü¡A¤½¥qªñ¤­¦~Àç·~¦¬¤J¡B²£«~Á`¦¬¤J¤Î®Ö¤ß²£«~¦¬¤J«ùÄò«O«ù°ª³t¼Wªø¡A¬ãµo¶O¥Î¤Î¾P°â/ºÞ²z¶O¥Î¼W³t«ùÄò©ñ½w¡A¨ä¸gÀçÁ«·l¦b 2022 ¦~ªï¨Ó­º¦¸´îÁ«¡A¸gÀç©Ê¬Õ§Q©äÂI¦³±æ¨ì¨Ó¡C2023¦~¡A¤½¥q¹ê²{Àç·~¦¬¤J174.2 »õ¤¸¡A¤ñ¤W¦~¦P´Á¼W¥[82.13%¡F¹ê²{²bÁ«·l67.2 »õ¤¸¡A¤ñ¤W¦~¦P´Á´î¤Ö69.3 »õ¤¸¡F³ø§i´Á¤º¡A¸gÀ笡°Ê²£¥Íªº²{ª÷¬y¶q²bÃB¬°-77.9»õ¤¸¡F¥þ¦~¬ãµo§ë¤J¬°128.1 »õ¤¸¡A»P¤W¦~¦P´Á¬Û¤ñ¼Wªø14.90%¡C2024¦~¤@©u«×¡A¤½¥q¹ê²{Àç·~¦¬¤J53.59»õ¤¸¡A¦P¤ñ¼Wªø74.8%¡F¹ê²{ÂkÄݤ_¤W¥«¤½¥qªÑªFªº²b§Q¼í-19.08»õ¤¸¡A¤W¦~¦P´Á¬°-26.13»õ¤¸¡AÁ«·l¦P¤ñÁY¤p¡C¦ÊÀÙ²£«~²Õ¦X¤´³B©ó°ª³t¼WªøºA¶Õ¡A¦b²£«~¦¬¤J«O«ù°ª¼W³tªº±¡ªp¤U¡A¤½¥qªº¥«­È¤ô¥­±N«ùÄò´£¤É¡C


    ¥«ªp¤ÀªR¡G¨È¤Ó°ÏªÑ¥«­Ó§Oµo®i¡A¥«³õÆ[±æÁpÀx§½Ä³®§Án©ú¤Î¬ü°ê³qµÈ¼Æ¾Ú¡A¥H¿Å¶q·í§½¦ó®É±Ò°Ê´î®§¡C¤é¥»ªÑ¥«²×¤î³s¤É¨â¤é¡A¤é¸g¥­§¡«ü¼Æ¦¬³ø38876ÂI¡A¶^258ÂI©Î0.66%¡C......§ó¦h

    ¥»¦a«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    Àô²y«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    A-H·¸»ù(§éÅý) ªí
    ¥N¸¹ ¤½¥q¦WºÙ H ªÑ
    ¦¬¥«»ù
    A ªÑ
    ¦¬¥«»ù
    A - H
    ·¸»ù

    ¨ä¥L
       ÂI¼Æ     ¤É¶^   ¤É¶^%
      
      


    ®ü¥~¬ã¨s³ø§i


    §ë¸êªA°È¤¤¤ß


    ¬d¸ß¼ö½u¡G2277 6666 ©Î investornotes@phillip.com.hk
    ¦pªG­¶­±Åã¥Ü¤£¥¿±`½ÐÂIÀ» ¦¹³B¬d¬Ý³sµ²©ó¸Uºûºô¤Wªºª©¥»¡C
     

    ¥»¤å©Ò¥]§tªº¸ê®Æ§¡¬°½÷¥ßµý¨é(­»´ä)¦³­­¤½¥q©Î¨äªþÄݤ½¥q (¡u¶°¹Î¡v) ±q¬Û«H¬°·Ç½Tªº¨Ó·½·j¶°¡A¦ý¹ï¥ô¦ó¦]«H¿à©Î°Ñ¦Ò¦³Ãö¤º®e©Ò¾É­Pªº·l¥¢¡A·§¤£­t³d¡C¥»¶°¹Î (©Î¨ä¹µ­û) ¥i¯à«ù¦³¥»¤å©Ò­z¦³Ãöªº§ë¸ê²£«~¡C¦UÃþ²£«~ªº­·ÀI¡A½Ð°Ñ¾\¥»¤½¥qºô­¶ http://www.phillip.com.hk¡m­·ÀI©ÜÅSÁn©ú¡n¡C

    ¦p±z¤£·Q¦A¦¬¨ú¹q¤l±À¼s¶l¥ó¡A½Ð«ö¦¹³B¡C

    ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

    Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.